Here's Why Altria (MO) is a Strong Value Stock

Zacks Investment Research highlights Altria Group (MO) as a potentially strong value stock, noting its expansion into smokeless products amid declining traditional cigarette use. Altria holds a Zacks Rank #3 (Hold) with a VGM Score of A and a Value Style Score of B, supported by a forward P/E ratio of 11.01. Five analysts have raised their fiscal 2025 earnings estimates in the last 60 days, increasing the Zacks Consensus Estimate to $5.39 per share, suggesting positive earnings revisions and potential for outperformance.

Analysis

Altria Group (MO) is navigating a challenging industry landscape, characterized by declining traditional cigarette consumption and heightened regulatory scrutiny, by strategically expanding into the smokeless product category where revenues from oral products are steadily rising. According to Zacks Investment Research, Altria currently holds a #3 (Hold) rank. While this suggests a neutral short-term outlook, Zacks' methodology indicates that for 'Hold' rated stocks, Style Scores of 'A' or 'B' are important for potential upside; Altria meets this with a strong VGM Score of 'A' and a Value Style Score of 'B'. The company's valuation is supported by a forward P/E ratio of 11.01. Significantly, positive momentum is evident in earnings expectations, as five analysts have revised their fiscal 2025 earnings estimates upwards in the last 60 days, increasing the Zacks Consensus Estimate by $0.07 to $5.39 per share. Coupled with an average earnings surprise of 1.3%, these factors suggest an improving fundamental picture despite the neutral rank, highlighting the potential efficacy of its strategic pivot.

Key Decisions for Investors

• Given Altria's #3 (Hold) Zacks Rank but strong 'A' VGM and 'B' Value Scores, alongside positive fiscal 2025 earnings estimate revisions to $5.39 per share, investors should monitor for further confirmation of fundamental improvement and successful execution in its smokeless category strategy.
• Value-oriented investors may find Altria's forward P/E ratio of 11.01 attractive, warranting a closer look, particularly if the positive trend in earnings estimate revisions and growth in reduced-risk products continues.
• Investors should closely track the revenue trajectory from Altria's oral and smokeless product segments and any further shifts in analyst consensus earnings estimates as key indicators of the company's ongoing business transformation and future performance.